Literature DB >> 2031614

Treatment of hyperkalaemia with intravenous salbutamol.

I A Murdoch1, R Dos Anjos, G B Haycock.   

Abstract

Thirteen children with hyperkalaemia were treated by intravenous infusions of salbutamol, 4 micrograms/kg over 20 minutes. Reductions in the mean (SD) plasma potassium concentrations, of 1.48 (0.5) and 1.64 (0.5) mmol/l were obtained at 40 and 120 minutes, respectively, after completion of the infusions. No side effects were noted.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2031614      PMCID： PMC1793005          DOI： 10.1136/adc.66.4.527

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease.

Authors:  C L Stemmer; G O Perez; J R Oster
Journal:  J Clin Pharmacol       Date:  1987-08       Impact factor: 3.126

2.  Inhaled bronchodilators and hypokalaemia.

Authors:  S R Smith; M J Kendall
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

3.  Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.

Authors:  P Wang; T Clausen
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

4.  Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.

Authors:  A Blumberg; P Weidmann; S Shaw; M Gnädinger
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

5.  Treatment of hyperkalaemia in renal failure: salbutamol v. insulin.

Authors:  X M Lens; J Montoliu; A Cases; J M Campistol; L Revert
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992
  5 in total
  5 in total

Review 1.  Acute renal failure in children: aetiology and management.

Authors:  G Filler
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol.

Authors:  M J Kemper; E Harps; H H Hellwege; D E Müller-Wiefel
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

Review 3.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

4.  Treatment of hyperkalaemia using intravenous and nebulised salbutamol.

Authors:  R J McClure; V K Prasad; J T Brocklebank
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 5.  Potassium homeostasis and its disturbances in children.

Authors:  J Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.